The director of the top three laboratory examination department was investigated

1

Another director of the laboratory was investigated

Recently, Anhui Provincial Discipline Inspection and Supervision Network issued a notice stating that the director of the laboratory of the Second Affiliated Hospital of Anhui Medical University is currently undergoing disciplinary review and supervision investigation due to suspected serious violations of discipline and law.

At present, the official has not yet notified the specific details of the above-mentioned case.

As we all know, because the heads of these departments have a certain right to speak in the procurement recommendations, application and use of drugs, medical devices, equipment, and inspection reagents, they are usually the target of "hunting" for drugs, medical consumables, and medical devices.

In fact, in the past, many people thought that the clinical laboratory was a "clear water yamen" in the hospital, but in fact, the clinical laboratory belongs to a department with a lot of oil and water.

You might think that the department in the hospital that can get the rebate should be the department with some large equipment, and the test paper is not valuable, so many people don't pay much attention to the laboratory.

Previously, media reports stated that some hospitals’ laboratory departments would receive a rebate based on 3% to 10% of the reagent’s selling price when purchasing in vitro diagnostic reagents.

In recent years, a large number of inspection department directors have been dismissed one after another, which also illustrates the problems in this industry.

2

Medical anti-corruption work is still the focus

Earlier, a procuratorial officer told the media that corruption and bribery in the medical and health sector involve many departments and personnel, and it is difficult for a single person to complete the crime.

As many as the chief of the bureau, the dean, the chief of medicine and equipment, the chief of finance, the purchaser, and the medical staff, often investigating a case leads to several cases, and one person leads to several people or even dozens of people, forming a series of nested cases.

Since pharmaceutical companies generally have to deal with hospitals, medical professionals have also become key inspection targets in medical anti-corruption work.

1.

Medical representatives once again became the key targets of medical anti-corruption and gained national attention.

2.

In order to obtain access qualifications or maintain long-term supply relationships for medical procurement, some medical agents pay bribes to medical staff, especially those who have a certain say in medical procurement recommendations and applications.

3.

According to the “China Discipline Inspection and Supervision News”, under the condition that “medicine to support doctors” is restricted by policies, some hospitals use reagents, consumables, or ask patients to do more inspections to “provide doctors with equipment”.

In fact, under a series of stringent investigations, many hospitals have taken the initiative to shut out non-compliant pharmaceutical companies.
From the National Health Commission's strengthening of medical anti-corruption and strict inspection of rebates, to the National Medical Insurance Bureau's large-volume purchases, the ultimate goal of squeezing drug prices is to eliminate drug sales and purify the pharmaceutical industry environment.

For pharmaceutical companies, the traditional pharmaceutical marketing method that relied on high drug prices and large channel space to drive sales will be completely subverted, and pharmaceutical companies must transform in time.